title: Enhanced external counterpulsation is an effective treatment for Syndrome X.
abstract: Enhanced external counterpulsation (EECP) was used to treat 30 patients with refractory angina due to cardiac Syndrome X, with an initial improvement in CCS angina class (3.57 to 1.43; p<0.001) and regional ischemia in all treated patients. At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem.
authors.forename: Kenneth D
authors.initials: KD
authors.lastname: Kronhaus
authors.forename: William E
authors.initials: WE
authors.lastname: Lawson
mesh_terms: D000368:Aged; D015908:Counterpulsation; D005260:Female; D006801:Humans; D008297:Male; D017566:Microvascular Angina / Q000601:surgery*; D008875:Middle Aged; D016896:Treatment Outcome